Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hubei Xiangyuan New Material Technology Inc. (300980.SZ)
Hanchuan, CN
Hubei Xiangyuan New Material Technology Inc. is a Chinese firm that specializes in the innovation, manufacturing, and distribution of advanced foam materials, particularly cross-linked polyolefin and silicone-based foams. The company offers a comprehensive range of products, including various types of polyethylene foams such as irradiation cross-linked and chemical crosslinked variants, alongside radiation-cross-linked, semirigid, and closed-cell long sheet foams. Their portfolio also features 520 polyolefin foam, polyurethane foam, HFPP foam, and silicone foam, among other specialized items. These versatile materials find extensive application across numerous industries. They are integral to automotive interiors, sports and leisure equipment, protective packaging and cushioning, medical devices, and air-conditioning systems. Furthermore, their uses extend to construction materials, electronic components, toys, pipe insulation (including anti-condensation solutions), diverse industrial applications, consumer products, and healthcare goods. Established in 2003, Hubei Xiangyuan New Material Technology Inc. maintains its headquarters in Hanchuan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.26% | -0.93% | -9.70% | +1.15% | +23.17% | +4.75% | +40.72% | +89.99% | +22.86% | -6.00% | -6.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+26.8% ★ Q1'26: +25.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+54.2% ★ Q1'26: +160.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-7.1% Q1'26: +0.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.6% Q1'26: +12.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.1% Q1'26: +5.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+26.1% Q1'26: -7.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.16× ★ Q1'26: 0.28× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
461.94M
est: 572.00M (-19.2%)
|
373.64M
est: 379.17M (-1.5%)
|
383.68M
est: 379.17M (+1.2%)
|
475.86M
est: 618.14M (-23.0%)
|
603.49M
est: 796.39M (-24.2%)
|
646.00M
646.00M – 646.00M
-18.9% YoY
|
| EBITDA |
122.96M
est: 151.25M (-18.7%)
|
85.07M
est: 100.26M (-15.2%)
|
92.72M
est: 100.26M (-7.5%)
|
107.25M
est: 144.07M (-25.6%)
|
123.39M
est: 185.62M (-33.5%)
|
150.56M
150.56M – 150.56M
-18.9% YoY
|
| EBIT |
103.61M
est: 106.37M (-2.6%)
|
61.40M
est: 70.51M (-12.9%)
|
59.73M
est: 70.51M (-15.3%)
|
50.40M
est: 91.04M (-44.6%)
|
52.02M
est: 117.29M (-55.6%)
|
95.14M
95.14M – 95.14M
-18.9% YoY
|
| Net Income |
87.74M
est: 90.58M (-3.1%)
|
56.67M
est: 50.08M (+13.1%)
|
41.02M
est: 50.08M (-18.1%)
|
25.58M
est: 120.45M (-78.8%)
|
49.70M
est: 165.68M (-70.0%)
|
103.44M
103.44M – 103.44M
-37.6% YoY
|
| SGA |
48.73M
est: 26.39M (+84.7%)
|
47.53M
est: 17.49M (+171.7%)
|
62.85M
est: 17.49M (+259.3%)
|
84.59M
est: 76.07M (+11.2%)
|
24.77M
est: 98.01M (-74.7%)
|
79.50M
79.50M – 79.50M
-18.9% YoY
|
| EPS |
0.86
est: 0.85 (+1.2%)
|
0.53
est: 0.47 (+12.8%)
|
0.38
est: 0.47 (-19.1%)
|
0.24
est: 0.90 (-73.2%)
|
0.37
est: 1.23 (-70.0%)
|
0.77
0.77 – 0.77
-37.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jianping Duan | Deputy GM & Director | — | male |
| Pan Wang | Secretary, Accounting Supervisor & Chief Financial Officer | — | female |
| Qiong Wei | GM & Director | — | female |
| Shi Ming Wang | Deputy General Manager | — | male |
| Yonghong Huang | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300980.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
